Urologist who has served as President of Hospital de Clínicas de Porto Alegre, a leading Brazilian university hospital, since 2024.
Brasil Silva Neto is President (Presidente) of Hospital de Clínicas de Porto Alegre (HCPA), the university hospital of the Universidade Federal do Rio Grande do Sul and one of Brazil's foremost academic medical centres, in office since 2024. A professor of urology, his clinical and research interests include prostate and other urological cancers.
| Title | Journal | Year |
|---|---|---|
| The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis | World Journal of Urology | 2020 |
| Urinary microRNAs expression in prostate cancer diagnosis: a systematic review | Clinical and Translational Oncology | 2020 |
| Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer | PLOS ONE | 2018 |
Shares Prostate cancer and the tags leadership, clinician-scientist, prostate cancer.
Shares Bladder & urothelial cancer, Prostate cancer and the tags leadership, clinician-scientist, prostate cancer.
Shares Prostate cancer and the tags leadership, clinician-scientist, prostate cancer.
Shares Bladder & urothelial cancer, Prostate cancer and the tags clinician-scientist, prostate cancer.
Shares Bladder & urothelial cancer, Prostate cancer and the tags leadership, clinician-scientist.
Shares Bladder & urothelial cancer, Prostate cancer and the tags leadership, clinician-scientist.
Shares Prostate cancer and the tags clinician-scientist, prostate cancer.
Shares Prostate cancer and the tags leadership, clinician-scientist.